Investment Summary |
|
|---|---|
| Date | 2022-09-14 |
| Target | Pandora Biosciences |
| Sector | Life Science |
| Investor(s) | Illumina |
| Deal Type | Stake Purchase |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1998 |
| Sector | Life Science |
| Employees | 10,590 |
| Revenue | 4.4B USD (2024) |
Illumina is a developer, manufacturer, and marketer of life science tools and integrated systems for the analysis of genetic variation and function. Illumina provides innovative sequencing and array-based solutions for genotyping, copy number variation analysis, methylation studies, gene expression profiling, and low-multiplex analysis of DNA, RNA, and protein. Illumina was formed in 1998 and is based in San Diego, California.
| DEAL STATS | # |
|---|---|
| Overall | 28 of 30 |
| Sector: Life Science M&A | 17 of 19 |
| Type: Stake Purchase M&A Deals | 13 of 13 |
| Country: South Africa M&A | 1 of 1 |
| Year: 2022 M&A | 13 of 13 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-09-14 |
Dama Health
London, United Kingdom Dama Health is a women's health company that offers precision screening to identify the most suitable contraception type and formulation, empowering women, people assigned to females at birth, and clinicians to make personalized reproductive health decisions. Dama Health is based in London, United Kingdom. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2023-01-09 |
Verogen
San Diego, California, United States Verogen is a developer, manufacturer, and sells forensic genomics products and services, including for next-generation sequencing. Verogen was formed in 2017 and is based in San Diego, California. |
Sell | $150M |
